Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 9, 623-630
eCollection

Health Provider Experiences With Galactagogues to Support Breastfeeding: A Cross-Sectional Survey

Affiliations

Health Provider Experiences With Galactagogues to Support Breastfeeding: A Cross-Sectional Survey

Alessandra N Bazzano et al. J Multidiscip Healthc.

Abstract

Background: Exclusive breastfeeding for infants up to 6 months is widely recommended, yet breastfeeding rates are relatively low in the US. The most common reason women stop breastfeeding early is a perceived insufficiency of milk. Galactagogues are herbal and pharmaceutical products that can help increase milk supply; however, data on their efficacy and safety is limited. Lactation consultants, obstetricians, and other health providers are an important point of contact for breastfeeding women experiencing challenges with lactation. This study explored providers' perceptions, experiences, and practices in relation to galactagogue recommendation.

Method: A cross-sectional survey was conducted among a convenience sample of English-speaking health providers in the US who counsel breastfeeding women and their infants.

Results: More than 70% of respondents reported to recommend galactagogues. The most frequently recommended galactagogue was fenugreek with respondents indicating that they recommend it either 'always' (8.5%) or 'most of the time' (14.9%) and 'sometimes' (46.8%). More than 80% of the respondents indicated that galactagogues were useful for their clients and only one-third reported side effects. Reasons for refraining from recommending galactagogues were insufficient evidence of its efficacy and safety. Respondents reported a wide variety of sources of information used for their own education about galactagogues.

Discussion: Despite little evidence regarding safety and efficacy, some galactagogues are widely recommended and often perceived to be useful. However, concerns about their efficacy and safety remain. In order to assure both providers and users about safety and efficacy, more robust studies as well as better pharmacovigilance systems are needed.

Keywords: clinical decision making; human milk; lactation; lactogenesis; nutrition.

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Frequency of providers recommendation, by galactagogue (n=47).
Figure 2
Figure 2
Dosing practices of providers who prescribe or recommend galactagogues.
Figure 3
Figure 3
Provider report of perceived usefulness and reported side effects.

Similar articles

See all similar articles

Cited by 1 article

References

    1. WHO The optimal duration of exclusive breastfeeding Report of the expert consultation. 2001. Available from: http://www.who.int/nutrition/publications/infantfeeding/WHO_NHD_01.09/en/
    1. Innocenti declaration on the protection, promotion and support of breastfeeding. Florence, Italy: 1990. Available from: http://www.who.int/about/agenda/health_development/events/innocenti_declaration_1990.pdf.
    1. American Academy of Pediatrics Breastfeeding and the use of human milk. Pediatrics. 2012;129(3):e827–841. - PubMed
    1. American College of Obstetrics and Gynecology Breastfeeding in underserved women: increasing initiation and continuation of breastfeeding. Committee Opinion No 570. Obstet Gynecol. 2013;122:423–428. - PubMed
    1. Lawrence RA. Breastfeeding, a Guide for the Medical Profession. 2nd ed. St. Louis, MO: Mosby; 1985.

LinkOut - more resources

Feedback